Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
Huju Chi, Chunman Li, Flora Sha Zhao, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Delivery technologies for cancer immunotherapy
Rachel Riley, Carl H. June, Róbert Langer, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 175-196
Open Access | Times Cited: 2112
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek, Francisco J. Cueto, Adriana M. Mujal, et al.
Nature reviews. Immunology (2019) Vol. 20, Iss. 1, pp. 7-24
Closed Access | Times Cited: 1973
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
Christopher B. Rodell, Sean P. Arlauckas, Michael F. Cuccarese, et al.
Nature Biomedical Engineering (2018) Vol. 2, Iss. 8, pp. 578-588
Open Access | Times Cited: 884
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses
Clément Anfray, Aldo Ummarino, Fernando Torres, et al.
Cells (2019) Vol. 9, Iss. 1, pp. 46-46
Open Access | Times Cited: 255
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
Benjamin Ruf, Bernd Heinrich, Tim F. Greten
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 112-127
Open Access | Times Cited: 233
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
Baharak Bahmani, Hua Gong, Brian T. Luk, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 218
Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases
Wei He, Neha Kapate, C. Wyatt Shields, et al.
Advanced Drug Delivery Reviews (2019) Vol. 165-166, pp. 15-40
Open Access | Times Cited: 195
Toll-Like Receptors: General Molecular and Structural Biology
Payam Behzadi, Herney Andrés García‐Perdomo, Tomasz M. Karpiński
Journal of Immunology Research (2021) Vol. 2021, pp. 1-21
Open Access | Times Cited: 174
Small-Molecule Modulators of Toll-like Receptors
Yibo Wang, Shuting Zhang, Hongyuan Li, et al.
Accounts of Chemical Research (2020) Vol. 53, Iss. 5, pp. 1046-1055
Closed Access | Times Cited: 166
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
Stefanie Mullins, John P. Vasilakos, Katharina Deschler, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 153
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
Sachin Bhagchandani, Jeremiah A. Johnson, Darrell J. Irvine
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113803-113803
Open Access | Times Cited: 124
Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
Christian Rolfo, Elisa Giovannetti, Pablo Martínez, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 83
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
Suprabhat Mukherjee, Ritwik Patra, Payam Behzadi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 61
Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
Chanyoung Song, Hathaichanok Phuengkham, Young Seob Kim, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 137
Delivery strategies of cancer immunotherapy: recent advances and future perspectives
Zhongwei Zhao, Liyun Zheng, Weiqian Chen, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 131
Immunoadjuvants for cancer immunotherapy: A review of recent developments
Asmita Banstola, Jee‐Heon Jeong, Simmyung Yook
Acta Biomaterialia (2020) Vol. 114, pp. 16-30
Closed Access | Times Cited: 107
Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment
Sara Saab, Hussein Zalzale, Zahraa Rahal, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 96
Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
Cindy Patinote, Nour Bou Karroum, Georges Moarbess, et al.
European Journal of Medicinal Chemistry (2020) Vol. 193, pp. 112238-112238
Open Access | Times Cited: 95
Targeting innate sensing in the tumor microenvironment to improve immunotherapy
Zhida Liu, Chuanhui Han, Yang‐Xin Fu
Cellular and Molecular Immunology (2019) Vol. 17, Iss. 1, pp. 13-26
Open Access | Times Cited: 89
Ultraviolet radiation-induced immunosuppression and its relevance for skin carcinogenesis
Prue H. Hart, Mary Norval
Photochemical & Photobiological Sciences (2017) Vol. 17, Iss. 12, pp. 1872-1884
Open Access | Times Cited: 88
Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines
Candido G. Da Silva, Marcel Camps, Tracy Li, et al.
Biomaterials (2019) Vol. 220, pp. 119417-119417
Closed Access | Times Cited: 76
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
Augusto Bleve, Barbara Durante, Antonio Sica, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5845-5845
Open Access | Times Cited: 74
pH-Responsive Nanoparticles for Cancer Immunotherapy: A Brief Review
Yunfeng Yan, Hangwei Ding
Nanomaterials (2020) Vol. 10, Iss. 8, pp. 1613-1613
Open Access | Times Cited: 73
Application of dendritic cells in tumor immunotherapy and progress in the mechanism of anti-tumor effect of Astragalus polysaccharide (APS) modulating dendritic cells: a review
Dong Wang, Qian Cui, Yan Yang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113541-113541
Open Access | Times Cited: 45
Preclinical Characterization and Phase I Study of an Anti–HER2-TLR7 Immune-Stimulator Antibody Conjugate in Patients with HER2+ Malignancies
Filip Janků, Sae‐Won Han, Toshihiko Doi, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 12, pp. 1441-1461
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top